Paul Tebbey News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Pfizer's chief development officer, Rod MacKenzie, is the Big Pharma's second executive to retire in early 2022. NIH Director Francis Collins will also hit the exit, before the end of this year. Sanofi poaches Gilead cancer executive Valeria Fantin to run its oncology research.

DURHAM, N.C., Oct. 06, 2021 (GLOBE NEWSWIRE) -- Heat Biologics, Inc. (“Heat”) (NASDAQ: HTBX), a clinical-stage biopharmaceutical company focused on developing first-in-class therapies to modulate the immune system, today announced